Status:
UNKNOWN
Hip Prosthesis Components Position
Lead Sponsor:
Mateusz Szymczak
Conditions:
Hip Arthrosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The purpose of the study is
Eligibility Criteria
Inclusion
- indication for hip replacement surgery
Exclusion
- pregnancy
- abnormal anatomy (hip dysplasia, fracture)
- previous srgery
Key Trial Info
Start Date :
June 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT05406271
Start Date
June 1 2022
End Date
December 31 2022
Last Update
June 6 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
District Hospital
Rypin, Kuyavian-Pomeranian Voivodeship, Poland, 87-500